Delcath Receives Orphan Drug Designation From FDA For Melphalan; Exelixis Up 50% After Meteroric METEOR Results Print E-mail
By Mary Davila   
Monday, 20 July 2015 19:20
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 20, 2015.  
Read more...
 
Bristol-Myers' HIV-1 Drug Approved In Europe; St. Jude Medical Receives FDA Approval for the Spinal Cord Stimulation Trial System Print E-mail
By David Fowler   
Thursday, 16 July 2015 23:52
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 16, 2015.  
Read more...
 
Argos Announces Completion of Print E-mail
By William Kent   
Wednesday, 15 July 2015 19:16
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 15, 2015.
Read more...
 
Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug; Ohr Pharma Announces Positive Results of

Error. Page cannot be displayed. Please contact your service provider for more details. (20)

a Phase II Clinical Study for OHR-102
Print E-mail
By Marilyn Mullen   
Monday, 13 July 2015 21:35
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 13, 2015.  
Read more...
 
IGI Labs Announces FDA Approval And Commercial Launch Of Diclofenac Sodium; Dynavax to Continue Phase 3 Study of HEPLISAV-B(TM) Print E-mail
By Josh Gee   
Thursday, 09 July 2015 19:12
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 9, 2015.  
Read more...
 
Intersect ENT Enrolls First Patient in Pivotal Study to Evaluate the NOVA Sinus Implant; Summit Therapeutics Receives FDA Fast Track Designation for SMT19969 Print E-mail
By William Kent   
Wednesday, 08 July 2015 19:55
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 8, 2015.
Read more...
 
pSivida Announces Top-Line Results from Phase II Study of Medidur; Esperion Announces Removal of Partial Clinical Hold for ETC-1002 Print E-mail
By David Fowler   
Tuesday, 07 July 2015 18:54
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 7, 2015.    
Read more...
 
Ignyta Announces Collaboration with UCSF For Clinical Trial of Entrectinib; Strensiq Receives Marketing Approval for Hypophosphatasia Print E-mail
By Josh Gee   
Monday, 06 July 2015 19:57
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 2, 2015.  
Read more...
 
Goldman Comments On Vertex After FDA Approval; Arrowhead Initiates Dosing of ARC-AAT in Patients Print E-mail
By William Kent   
Thursday, 02 July 2015 22:51
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 2, 2015.
Read more...
 
Gilead Submits NDA to FDA for Single Tablet Regimen for HIV; CEL-SCI Reports June Patient Enrollment Print E-mail
By David Fowler   
Wednesday, 01 July 2015 20:02
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 1, 2015.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 6 of 369
BMR:1